Biocompatible Nanoparticles as a Platform for Enhancing Antitumor Efficacy of Cisplatin–Tetradrine Combination

Combination therapy has been a standard strategy in the clinical tumor treatment. We have demonstrated that combination of Tetradrine (Tet) and Cisplatin (CDDP) presented a marked synergistic anticancer activity, but inevitable side effects limit their therapeutic concentration. Considering the diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fangcen, Wang, Xinyue, Liu, Qin, Zhang, Huan, Xie, Li, Wang, Qin, Li, Lin, Li, Rutian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Nano Express
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046896/
https://www.ncbi.nlm.nih.gov/pubmed/33855646
http://dx.doi.org/10.1186/s11671-021-03511-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046896/
https://www.ncbi.nlm.nih.gov/pubmed/33855646
http://dx.doi.org/10.1186/s11671-021-03511-4

Ejemplares similares